HedgeMountain

GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV

Boston, MA · CIK 1917910
506(c)

GMO Equity Dislocation Investment Fund, a sub-fund of GMO Investments ICAV is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Dec 11, 2025, the fund has sold $179,600,966 of interests to 3 investors since its first sale in Mar 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Arron Day; David Bohan; John Fitzpatrick.

Performance

No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.

Is this your fund? Report your monthly returns · How performance works

Total raised
$179,600,966Cumulative sales reported on Form D
Investors
3
First sale
Mar 7, 2022
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(c)May advertise; investors must be verified as accredited
Key people and entities
Arron Day; David Bohan; John Fitzpatrick
Latest Form D
Dec 11, 2025

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures

Size compared with every hedge fund

Raised more than 57% of the 472 hedge funds based in Massachusetts, and more than 67% of all 10,157 that report sales.

Other funds with the same team

More hedge funds in Boston